Charles River Laboratories CRL RMS — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's rms — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's RMS — capex?
- Charles River Laboratories (CRL) reported RMS — capex of $11.57M in Q1 2026.
- How has Charles River Laboratories's RMS — capex changed year-over-year?
- Charles River Laboratories's RMS — capex increased by 58.8% year-over-year, from $7.29M to $11.57M.
- What is the long-term trend for Charles River Laboratories's RMS — capex?
- Over 2 years (2023 to 2025), Charles River Laboratories's RMS — capex has grown at a -14.3% compound annual growth rate (CAGR), from $52.82M to $38.84M.
- What does RMS — capex mean?
- The amount spent on physical assets and infrastructure to support the segment's operations.
- How do you interpret RMS — capex?
- Higher spending may indicate investments in future growth or capacity expansion, while lower spending could suggest a focus on cash preservation or reduced growth requirements.
- How does RMS — capex compare across companies?
- Standard metric for capital-intensive business units in the research and manufacturing sectors.